Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,406,089
- Total 13F shares
- 236,653,399
- Share change
- +491,126
- Total reported value
- $114,743,267,144
- Put/Call ratio
- 77%
- Price per share
- $484.82
- Number of holders
- 1,597
- Value change
- +$569,969,794
- Number of buys
- 820
- Number of sells
- 693
Report period
Q1 2025
Institutions
1,597
Top holders
10
VRTX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
3.6%
|
9,220,827
|
$4,642,686,284 | $0 | 31 Dec 2024 | |
| Capital World Investors |
13F
|
Company |
11%
|
28,325,695
|
$11,406,666,988 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.1%
|
23,258,288
|
$9,366,112,578 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.6%
|
21,825,470
|
$8,789,116,493 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
11,979,405
|
$4,823,868,882 | — | 31 Dec 2024 | |
| Capital Research Global Investors |
13F
|
Company |
4.1%
|
10,428,951
|
$4,199,713,394 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.5%
|
6,313,107
|
$2,542,288,504 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.3%
|
5,916,084
|
$2,382,407,028 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
5,648,236
|
$2,269,072,781 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.7%
|
4,317,762
|
$1,738,762,592 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.5%
|
3,920,020
|
$1,578,592,054 | — | 31 Dec 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.5%
|
3,772,789
|
$1,519,302,000 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
3,414,324
|
$1,374,948,275 | — | 31 Dec 2024 | |
| Amundi |
13F
|
Individual |
1.3%
|
3,281,205
|
$1,350,937,937 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
3,171,387
|
$1,277,118,367 | — | 31 Dec 2024 | |
| EDGEWOOD MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,956,608
|
$1,190,626,042 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.1%
|
2,833,889
|
$1,141,277,084 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,721,049
|
$1,095,766,431 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.95%
|
2,419,353
|
$974,273,385 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.92%
|
2,329,219
|
$937,976,491 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.9%
|
2,288,498
|
$921,578,146 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.79%
|
2,015,523
|
$811,635,380 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.75%
|
1,898,457
|
$764,508,506 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.74%
|
1,884,153
|
$758,748,421 | — | 31 Dec 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.73%
|
1,850,858
|
$745,340,347 | — | 31 Dec 2024 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
0.71%
|
1,815,950
|
$731,283,065 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.69%
|
1,759,216
|
$708,436,198 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.66%
|
1,690,700
|
$680,846,000 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
1,663,849
|
$670,031,967 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.57%
|
1,450,959
|
$584,302,000 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.55%
|
1,401,734
|
$564,478,310 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.55%
|
1,397,209
|
$562,656,064 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.55%
|
1,389,605
|
$559,593,932 | — | 31 Dec 2024 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
1,091,522
|
$435,899,311 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.41%
|
1,051,111
|
$423,282,400 | — | 31 Dec 2024 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.38%
|
970,662
|
$390,885,589 | — | 31 Dec 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.35%
|
880,214
|
$354,462,178 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.34%
|
873,755
|
$351,725,910 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.34%
|
863,036
|
$347,544,598 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
843,075
|
$339,506,303 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.33%
|
839,672
|
$338,135,914 | — | 31 Dec 2024 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.32%
|
823,627
|
$331,674,567 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.3%
|
760,517
|
$306,260,278 | — | 31 Dec 2024 | |
| Swiss National Bank |
13F
|
Company |
0.29%
|
729,200
|
$293,648,840 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
698,706
|
$281,253,595 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
689,652
|
$277,722,872 | — | 31 Dec 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.26%
|
664,523
|
$267,603,412 | — | 31 Dec 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
659,533
|
$265,593,939 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
627,517
|
$252,684,539 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.23%
|
596,555
|
$240,232,698 | — | 31 Dec 2024 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2025
As of 31 Mar 2025,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,597 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
236,653,399 shares.
The largest 10 holders included
Capital World Investors, VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, STATE STREET CORP, JPMORGAN CHASE & CO, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, and JENNISON ASSOCIATES LLC.
This page lists
1,606
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
1,542
Q1 2025 holders
1,597
Holder diff
55
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.